Methods and clinical biomarker discovery for targeted proteomics using Olink technology
PROTEOMICS – Clinical Applications · 2024-09 · 18 (5)
DOI: 10.1002/prca.202300233 ↗Abstract
Abstract Purpose This paper is to offer insights for designing research utilizing Olink technology to identify biomarkers and potential therapeutic targets for disease treatment. Experimental Design We discusses the application of Olink technology in oncology, cardiovascular, respiratory and immune‐related diseases, and Outlines the advantages and limitations of Olink technology. Results Olink technology simplifies the search for therapeutic targets, advances proteomics research, reveals the pathogenesis of diseases, and ultimately helps patients develop precision treatments. Conclusions Although proteomics technology has been rapidly developed in recent years, each method has its own disadvantages, so in the future research, more methods should be selected for combined application to verify each other.
EUVIMED